Diagnostic Tests

Medea Inc. distributes multi-panel diagnostic tests that detect RSV, Influenza A/B, and COVID-19 from a single sample—helping organizations respond quickly and confidently to respiratory illness outbreaks. Available in both Over-the-Counter (OTC) and Point-of-Care (POC) formats, these tests are designed to meet the needs of diverse environments, from clinical settings to community-based programs.

Backed by Medea’s extensive experience in pharmaceutical and medical supply distribution, our diagnostic solutions support healthcare providers, workplaces, schools, and government agencies that require fast, reliable results to guide decision-making, reduce downtime, and protect public health. Medea works closely with trusted manufacturers to ensure consistent supply, regulatory compliance, and dependable performance—especially during periods of heightened demand.

Whether supporting routine screening, outbreak response, or large-scale public health initiatives, Medea’s diagnostic tests provide a streamlined, efficient approach to respiratory testing while leveraging the operational reliability and distribution expertise Medea is known for.